Genistein binds and activates the three different types of estrogen receptors (ERα, ERβ and GPER) [56,57], possibly explaining the multiple potential mechanisms of action proposed for genistein to alter breast cancer risk and risk of recurrence. The gene discussed is ESR2; the disease is breast carcinoma.